Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

LIPI may improve patient selection for ICI and guide treatment adjustments according to on-treatment dynamics in a pancancer context.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2025-02-01
DOI
https://doi.org/10.1007/s00262-024-03933-w
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

Bárbara Adamo, Laura Mezquita, Begoña Mellado, Lydia Gaba et al.
1 citations
Cancer Immunology Immunotherapy
Cancer Immunotherapy and Biomarkers
1.05
article

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

Bárbara Adamo, Laura Mezquita, Begoña Mellado, Lydia Gaba, Fara Brasó‐Maristany, Iván Victoria, Òscar Reig, Azucena E. González Navarro, Joan Maurel, Neus Basté, Núria Viñolas, Miquel Nogué, Débora Moreno, Patricia Galván, Manel Juan, Esther Sanfeliu, Javier Garciá Corbacho, Tamara Saurí, Laura Angelats, Alberto Indacochea, Aleix Prat, Francesco Schettini, Estela Pineda
article en
1 citations

Abstract

LIPI may improve patient selection for ICI and guide treatment adjustments according to on-treatment dynamics in a pancancer context.

Cancer Immunology ImmunotherapyVol. 74(3)
Breast Cancer Research Foundation (US), Hospital General de Granollers (ES), Hospital Quirónsalud Barcelona (ES), Hospital Clínic de Barcelona (ES), Hospital Clínico Universitario Virgen de la Victoria (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Instituto de Investigación Biomédica de Málaga (ES), Universitat de Barcelona (ES)
Universitat de Barcelona, European Society for Medical Oncology, Instituto de Salud Carlos III
Openalex Percentile: Top 26%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.